Trade

Jubilant Pharmova share price

Balanced risk
  • 28%Low risk
  • 28%Moderate risk
  • 28%Balanced risk
  • 28%High risk
  • 28%Extreme risk
  • ₹1,034.90(-1.46%)
    January 13, 2026 15:29:08 PM IST
    • NSE
    • BSE
  • Vol : 121.20 K (NSE + BSE)
    Last 20 day avg : 114.33 K

Jubilant Pharmova is trading -1.46% lower at Rs 1,034.90 as compared to its last closing price. Jubilant Pharmova has been trading in the price range of 1,050.10 & 1,033.65. Jubilant Pharmova has given -2.12% in this year & -1.88% in the last 5 days. Jubilant Pharmova has TTM P/E ratio 35.80 as compared to the sector P/E of 23.01.There are 4 analysts who have initiated coverage on Jubilant Pharmova. There are 0.00 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 120.30 Crores in its last quarter.Listed peers of Jubilant Pharmova include Torrent Pharmaceuticals (-0.21%), Cipla (-1.22%), Sun Pharmaceutical Industries (-0.61%).The Mutual Fund holding in Jubilant Pharmova was at 7.13% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Jubilant Pharmova was at 16.56% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 13, 2026, 09:18 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.12
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.44
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.48
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.31
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
1,033.65
Highest
1,050.10
52 week range
Lowest
823.70
Highest
1,250.00
Jubilant Pharmova News
Jubilant Pharmova Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Torrent Pharmaceuticals
Bullish
3,940.00-0.211,33,342.1467.3217.10.8317.62
Cipla
Bearish
1,448.15-1.221,16,977.4722.953.870.870.81
Sun Pharmaceutical Industries
Neutral
1,726.30-0.614,14,772.5236.245.770.920.50
Divi's Laboratories
Neutral
6,433.00-0.851,70,685.1878.6111.520.460.01
Dr Reddy's Laboratories
Bearish
1,190.35-2.0899,378.2718.633.140.632.34
Mutual Fund Ownership
View all
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 16.44
  • % of AUM 3.78
Kotak Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 33.04
  • % of AUM 2.65
Kotak Special Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 52.83
  • % of AUM 2.53
Kotak MNC Fund Regular Growth
NA
  • Amount Invested (Cr.) 42.50
  • % of AUM 1.90
HDFC Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 30.32
  • % of AUM 1.78
Jubilant Pharmova Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-10-31Quarterly Results
2025-07-29Quarterly Results
2025-05-16Audited Results & Final Dividend
2025-01-31Quarterly Results
2024-10-25Quarterly Results
About the company Jubilant Pharmova
  • IndustryBiotechnology & Drugs
  • ISININE700A01033
  • BSE Code530019
  • NSE CodeJUBLPHARMA
Jubilant Pharmova Limited is an India-based integrated pharmaceutical company. The Company’s segments include Radiopharma, Allergy Immunotherapy, Contract Development and Manufacturing Organisation-Sterile Injectables, Generics, Contract Research, Development and Manufacturing Organisation, Proprietary Novel Drugs, and Management Services. The Radiopharma segment comprises radiopharmaceuticals, including radio pharmacies. The Contract Development and Manufacturing Organisation-Sterile Injectables segment includes contract development and manufacturing organisation-sterile injectables products. The Generics segment includes solid dosage formulations. The Contract Research, Development and Manufacturing Organisation segment includes drug discovery services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment includes patient-focused biopharmaceutical businesses working to address unmet medical needs in oncology and autoimmune diseases.
  • Management Info
  • Hari BhartiaNon-Executive Co-Chairman of the Board
  • Arun SharmaChief Financial Officer
  • Naresh KapoorCompliance Officer, Company Secretary
  • Arjun BhartiaJoint Managing Director, Executive Director
  • Priyavrat BhartiaManaging Director, Executive Director
Jubilant Pharmova Share Price FAQs

Jubilant Pharmova is trading at 1034.90 as on Tue Jan 13 2026 09:59:08. This is -1.46% lower as compared to its previous closing price of 1050.25.

The market capitalization of Jubilant Pharmova is 16486.36 Cr as on Tue Jan 13 2026 09:59:08.

The average broker rating on Jubilant Pharmova is Buy. The breakup of analyst rating is given below -

  • 0.00 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 1 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Jubilant Pharmova is 1250.00 whereas the 52 wk low is 823.70

Jubilant Pharmova can be analyzed on the following key metrics -

  • TTM P/E: 35.80
  • Sector P/E: 23.01
  • Dividend Yield: 0.48%
  • D/E ratio: 0.44

Jubilant Pharmova reported a net profit of 839.40 Cr in 2025.

The Mutual Fund Shareholding was 7.13% at the end of 30 Sep 2025.

Quick Links
EQUITY QUICK LINKS
Jubilant Pharmova QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Jubilant Pharmova share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.